Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies.
Sánchez-Martín D, Martínez-Torrecuadrada J, Teesalu T, Sugahara KN, Alvarez-Cienfuegos A, Ximénez-Embún P, Fernández-Periáñez R, Martín MT, Molina-Privado I, Ruppen-Cañás I, et al. Proc Natl Acad Sci U S A. 2013 Aug 20; 110(34):13791-6. Epub 2013 Aug 5.